Clinical Trial: Efficacy and Safety of HUC3-637 in Patients With Primary Open Angle Glaucoma or Ocular Hypertension

U.S., Jan. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07335211) titled 'Efficacy and Safety of HUC3-637 in Patients With Primary Open Angle Glaucoma or Ocular Hypertension' on Jan. 05.

Brief Summary: A multicenter, randomized, single-blind, active controlled, phase III clinical trial to evaluate the efficacy and safety of HUC3-637 in patients with primary open angle glaucoma or ocular hypertension

Study Start Date: Jan., 2026

Study Type: INTERVENTIONAL

Condition: Primary Open Angle Glaucoma (POAG) Ocular Hypertension

Intervention: DRUG: HUC3-637

Ophthalmic solution instilled directly into the eye (topical ocular administration)

DRUG: HUC3-637-R

Ophthalmic solution instilled directly into the ey...